Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping

Genes Chromosomes and Cancer

Volumn 25, Issue 1, 1999, Pages 53-59

  Padilla Nash, Hesed M ^a,b   Nash, William G ^b   Padilla, George M ^c   Roberson, Kathryn M ^c   Robertson, Gary N ^c   Macville, Merryn ^a   Schröck, Evelin ^a   Ried, Thomas ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b H and W Cytogenetic Services Inc   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CHROMOSOME ANALYSIS; CHROMOSOME PAINTING; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; Y CHROMOSOME;

AGED; CARCINOMA; CHROMOSOME BANDING; CHROMOSOME PAINTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032934462     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T     Document Type: Article

References (12)

1. Fletcher J. 1997. Renal and bladder cancers. In Wolman SR, Sell S, editors. Human cytogenetic cancer markers. Totowa, NJ: Humana Press, p 186-202.
2. Garini Y, Macville M, du Manoir S, Buckwald RA, Lavi M, Katzir N, Vine D, Bar-Am I, Schröck E, Cabib D, Ried T. 1996. Spectral karyotyping. Bioimaging 4:65-72.
3. ISCN. Mitelman F, editor. 1995. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger.
4. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schröck E, Ried T. 1996. Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 14:312-315.
5. Macville M, Veldman T, Padilla-Nash H, Wangsa D, O'Brien P, Schröck E, Ried T. 1997. Spectral karyotyping, a 24-colour FISH rechnique for the identification of chromosomal rearrangements. Histochem Cell Biol 108:299-305.
6. Macville M, Schröck E, Padilla-Nash H, Keck C, Ghadimi B, Zimonjic D, Popescu N, Ried T. 1999. Comprehensive and definitive molecular cytogenetic characterization of HeLa Cells by spectral karyotyping. Cancer Res. 59:141-150.
7. Mitelman F, editor. 1994. Catalog of Chromosome Aberrations in Cancer, 5th ed. New York: Wiley-Liss.
8. Modi WS, Nash WG, Ferrari AC, O'Brien SJ. 1987. Cytogenetic methodologies for gene mapping and comparative analysis in mammalian cell culture systems. Gene Anal Techn 4:75-85.
9. Roberson KM, Yancey DR, Padilla-Nash H, Edwards DW, Nash W, Jacobs S, Padilla GM, Larchian WA, Robertson CN. 1998. Isolation and characterization of a novel human bladder cancer cell line: BK-10. In Vitro Cell Dev Biol Animal 34:537-544.
10. Sandberg AA, Berger CS. 1994. Review of chromosome studies in urological tumors. II. Cytogeneties and molecular genetics of bladder cancer. J Urol 151:545-560.
11. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolour spectral karyotyping of human chromosomes. Science 273:494-497.
12. Veldman T, Vignon C, Schröck E, Rowley JD, Ried T. 1997. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406-410.